Who Files VAERS Reports?

The VAERS Reporting Ecosystem

VAERS accepts reports from multiple sources, each bringing different perspectives and motivations to adverse event reporting. Understanding who files reports helps interpret patterns in the data and identify potential biases in reporting behavior.

The distribution of reports by administration context shows that private practicesettings account for the largest share at 32.7%, followed by other healthcare and institutional contexts.

Breaking Down the Reporting Sources

Private Practice Dominance

Private healthcare practices lead VAERS reporting, which makes sense given that most vaccinations in the United States occur in private medical settings. Private providers have several advantages for reporting:

• Direct patient relationships that facilitate follow-up
• Established systems for documenting patient care
• Legal and professional obligations to report adverse events
• Familiarity with VAERS reporting procedures

Public Health and Institutional Reporting

Public health departments and other institutional settings also contribute significantly to VAERS:

• Public Health: Mass vaccination clinics, public health investigations, and surveillance activities
• Military: Comprehensive healthcare system with systematic adverse event monitoring
• Workplace: Occupational health programs, especially for healthcare workers
• Pharmacies: Retail pharmacy vaccination programs with growing market share

Route of Administration Patterns

The route of administration data provides additional context about vaccination patterns:

• Intramuscular: 64.8% (1,140,107 reports)
• SYR: 12.3% (216,415 reports)
• OT: 9.9% (173,828 reports)
• Subcutaneous: 9.2% (161,716 reports)

The predominance of intramuscular administration reflects standard vaccination practice for most routine vaccines, while other routes represent specialized vaccines or specific populations.

Reporting Mandates and Incentives

Different settings have varying reporting requirements and incentives:

• Healthcare providers: Professional obligation to report serious adverse events
• Vaccine manufacturers: Required to report all adverse events they become aware of
• Public health departments: Surveillance mandate for population health monitoring
• Patients and families: Voluntary reporting with no legal requirement

These different mandates can create reporting patterns that reflect regulatory requirements as much as actual adverse event occurrence.

Quality and Detail Variations

Report quality often varies by source:

• Healthcare provider reports: Usually include more medical detail and context
• Patient reports: May lack medical terminology but provide valuable symptom descriptions
• Institutional reports: Often have standardized reporting procedures and follow-up
• Manufacturer reports: May be secondary reports based on information from others

Geographic and Demographic Influences

Reporting patterns also reflect healthcare delivery patterns:

• Urban areas with more healthcare providers may generate more reports
• Regions with active public health departments may have higher reporting rates
• Areas with more retail pharmacy vaccinations may show different reporting patterns
• Military populations have more systematic reporting through dedicated healthcare systems

The Rise of Pharmacy Reporting

One significant trend in recent years has been the growth of pharmacy-based vaccination. During the COVID-19 pandemic, pharmacies became primary vaccination sites for millions of Americans. This shift has implications for VAERS reporting:

• Pharmacists may have different reporting patterns than physicians
• Pharmacy systems may facilitate more standardized reporting
• Patients vaccinated at pharmacies may be less likely to have adverse events followed up by a primary care provider
• The convenience of pharmacy vaccination has increased overall vaccination rates, which in turn increases VAERS report volume

As pharmacy vaccination expands beyond flu and COVID-19 to include shingles, RSV, and other adult vaccines, understanding pharmacy reporting patterns becomes increasingly important for interpreting VAERS data.

Patient Self-Reporting

A growing share of VAERS reports comes from patients and their families rather than healthcare providers. Patient reports are valuable because they capture events that providers might not learn about, but they also tend to:

• Use less precise medical terminology
• Include more subjective symptom descriptions
• Be influenced by media coverage and online discussion
• Lack supporting medical documentation

Neither patient nor provider reports are inherently more reliable — they complement each other. Provider reports offer clinical precision; patient reports capture the lived experience.

Implications for Data Interpretation

Understanding who reports helps interpret VAERS data more accurately:

• Higher reporting from certain settings may reflect accessibility rather than safety issues
• Professional reporting requirements may create more complete data for some populations
• Voluntary reporting by patients may be influenced by awareness campaigns or media coverage
• Institutional variations may affect the types and severity of events reported